David Domzalski
CIK 1727794 · PRESIDENT AND CEO · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$284.5K
Companies
3
Total Filings
66
Lifetime Open-Market Net
-$10.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYNE | PRESIDENT AND CEO | 438,779 | $0.65 | $284.5K | $103.6K | 40 | 2026-06-02 |
| VYNE Therapeutics Inc. (MNLO) Delisted | President and CEO | 1,240,966 | — | — | $0 | 5 | 2020-07-02 |
| Foamix Pharmaceuticals Ltd. (FOMX) Delisted | CEO | 324,028 | — | — | -$113.9K | 20 | 2020-03-03 |
Recent Filings · Page 5 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-07-02 | VYNE Therapeutics Inc. (MNLO) Delisted | Tax (F) | −6,239 | -$10.8K | EDGAR |
| 2020-05-08 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | +680,000 | $0 | EDGAR |
| 2020-04-07 | VYNE Therapeutics Inc. (MNLO) Delisted | Mixed | +379,717 | -$16.5K | EDGAR |
| 2020-04-02 | VYNE Therapeutics Inc. (MNLO) Delisted | Tax (F) | −4,456 | -$11.9K | EDGAR |
| 2020-03-11 | — | Disp (D) | −324,028 | $0 | |
| 2020-03-11 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | +191,952 | $0 | EDGAR |
| 2020-03-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | +4,705 | $12.6K | EDGAR |
| 2020-02-24 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | +103,248 | $0 | EDGAR |
| 2020-01-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Tax (F) | −2,751 | -$9.0K | EDGAR |
| 2019-12-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | +9,842 | $21.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.